Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 10 EP applications Thomas Peter Gschwend has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 10, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13734849

NEW PROCESS FOR THE PREPARATION OF 2-CYCLOPENTYL-6-METHOXY-ISONICOTINIC ACID

IPC classification:
C07D 213/85, C07D 213/79, C07C 45/67
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13779378

PROCESS FOR THE PREPARATION OF!(2Z,5Z)-5-(3-CHLORO-4-((R)-2,3-DIHYDROXYPROPOXY)BENZYLIDENE)-2-(PROPYLIMINO)-3-!(O-TOLYL)THIAZOLIDIN-4-ONE AND INTERMEDIATE USED IN SAID PROCESS

IPC classification:
C07D 277/54, C07C 47/575
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION IN PROGRESS
EP14715428

NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS

IPC classification:
A61K 31/445, A61K 31/435, C07D 211/58, C07D 471/04, C07D 417/14, C07D 401/12, C07D 213/75, C07D 413/14, C07D 401/14, C07D 403/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14715427

PYRIDIN-4-YL DERIVATIVES

IPC classification:
A61P 37/00, A61K 31/4433, C07D 413/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP12704125

2-METHOXY-PYRIDIN-4-YL DERIVATIVES

IPC classification:
A61P 37/00, A61K 31/4439, C07D 413/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14799473

TRICYCLIC PIPERIDINE COMPOUNDS

IPC classification:
A61P 11/06, A61K 31/437, C07D 513/14
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP15808184

PHARMACEUTICAL COMBINATION COMPRISING A SELECTIVE S1P1 RECEPTOR AGONIST

IPC classification:
A61P 11/06, A61P 1/04, A61P 1/00, A61P 25/00, A61P 17/00, A61P 27/02, A61P 11/02, A61P 13/12, A61P 19/02, A61P 35/04, A61P 35/00, A61P 3/10, A61P 17/06, A61P 37/06, A61K 31/426, A61K 31/4015, A61K 31/225, A61K 31/22
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made
EP15807916

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

IPC classification:
A61P 1/04, A61P 1/00, A61P 25/00, A61P 17/00, A61P 27/02, A61P 11/02, A61P 13/12, A61P 19/02, A61P 11/06, A61P 35/04, A61P 35/00, A61P 3/10, A61P 17/06, A61P 37/06, A61K 31/426
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made
EP16719875

TRICYCLIC PIPERIDINE COMPOUNDS

IPC classification:
A61P 1/00, A61P 35/00, A61P 11/00, A61K 31/4375, C07D 471/14
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made
EP16734754

NADPH OXIDASE 4 INHIBITORS

IPC classification:
A61K 31/428, A61K 31/423, C07D 417/12, C07D 413/12, C07D 413/14, C07D 277/62, C07D 263/58, C07D 263/54
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made

Please Sign in to use this feature